Page last updated: 2024-08-16

technetium tc 99m sestamibi and amifostine anhydrous

technetium tc 99m sestamibi has been researched along with amifostine anhydrous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biber, Z; Ertay, T; Medine, I; Teksoz, S; Unak, P; Yurekli, Y	1

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and amifostine anhydrous

Article	Year
Radiopharmaceutical model using 99mTc-MIBI to evaluate amifostine protection against doxorubicin cardiotoxicity in rats. Annals of nuclear medicine, 2005, Volume: 19, Issue:3 Topics: Amifostine; Animals; Antineoplastic Agents; Cardiomyopathies; Cardiotonic Agents; Cytoprotection; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Male; Models, Animal; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium Tc 99m Sestamibi; Treatment Outcome	2005

Article

Year

Radiopharmaceutical model using 99mTc-MIBI to evaluate amifostine protection against doxorubicin cardiotoxicity in rats.

Annals of nuclear medicine, 2005, Volume: 19, Issue:3

Topics: Amifostine; Animals; Antineoplastic Agents; Cardiomyopathies; Cardiotonic Agents; Cytoprotection; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Male; Models, Animal; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium Tc 99m Sestamibi; Treatment Outcome

2005